Agency Forms Undergoing Paperwork Reduction Act Review, 78132-78133 [2020-26631]
Download as PDF
<![CDATA[
78132
Federal Register / Vol. 85, No. 233 / Thursday, December 3, 2020 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–26630 Filed 12–2–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–1074]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Colorectal
Cancer Control (CRCCP) Monitoring
Activities to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on June 5,
2020 to obtain comments from the
public and affected agencies. CDC
received two non-substantive public
comments and provided responses to
each. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
VerDate Sep<11>2014
19:48 Dec 02, 2020
Jkt 253001
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Colorectal Cancer Control Program
(CRCCP) Monitoring Activities (OMB
Control No. 0920–1074, Exp. 7/31/
2020)—Reinstatement with Change—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting a Reinstatement
with Change to OMB Control No. 0920–
1074. CDC proposes use of a modified
annual grantee survey instrument
(renamed ‘‘Annual Awardee Survey’’), a
modified clinic-level data collection
instrument, and a new awardee-level
Quarterly Program Update. The number
of respondents will increase from 30 to
35 awardees, and the total estimated
annualized burden will increase.
Colorectal cancer (CRC) is the second
leading cause of death from cancer in
the United States among cancers that
affect both men and women. There is
substantial evidence that CRC screening
reduces the incidence of and death from
the disease. Screening for CRC can
detect disease early, when treatment is
more effective, and prevent cancer by
finding and removing precancerous
polyps. Of individuals diagnosed with
early stage CRC, more than 90% live
five or more years. To reduce CRC
morbidity, mortality, and associated
costs, use of CRC screening tests must
be increased among age-eligible adults
with the lowest CRC screening rates.
The purpose of the Colorectal Cancer
Control Program (CRCCP) is to partner
with health systems and their
individual primary care clinics to
implement evidence-based
interventions (EBIs) to increase CRC
screening among defined populations of
adults ages 50–75 that have CRC
screening rates lower than the national,
regional, or local rate.
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
In 2020, CDC issued a new funding
opportunity, Public Health and Health
System Partnerships to Increase
Colorectal Cancer Screening in Clinical
Settings (DP20–2002), a five-year
cooperative agreement to increase CRC
screening among defined populations of
adults ages 50–75 that have CRC
screening rates lower than the national,
regional, or local rate. DP20–2002 funds
recipients to partner with health
systems and their primary care clinics to
implement multiple EBIs, partner with
organizations to support
implementation of EBIs in those clinics,
and collect high-quality clinic-level data
when a clinic is recruited to participate
(baseline) and annually thereafter to
monitor EBI implementation and assess
screening rate changes. DP20–2002
eliminates funding to provide direct
clinical service delivery. However,
DP20–2002 requires recipients to
conduct a formal readiness assessment
of potential clinics to implement EBIs,
use assessment findings to select
appropriate EBIs for implementation,
and provide clinics with limited
financial resources to support follow-up
colonoscopies for under- and uninsured
patients after an abnormal CRC
screening test.
CDC proposes three information
collections—a modified Annual
Awardee Survey, a modified ClinicLevel Data Collection Instrument, and a
new awardee-level Quarterly Program
Update—to reflect modified goals for
the new cooperative agreement and a
modified monitoring plan.
The Annual Awardee Survey
eliminates questions related to clinic
service delivery, which is no longer
funded under DP20–2002. In addition,
many program management questions
were eliminated and will now be
gathered via the Quarterly Program
Update on a quarterly basis to better
inform CDC technical assistance (TA).
The survey now includes five items
regarding the effect of COVID–19 on
CRCCP implementation at the grantee
level.
The modified clinic-level data
collection instrument was reorganized
for increased efficiency and overall data
quality improvement. In addition,
wording and responses for many
variables and their response options
have undergone minor revisions to
better capture awardees’ partnerships
with both health systems and clinics,
and appropriate capture of baseline and
annual variables. The instrument
gathers information to assess health
system and clinic characteristics;
program reach; CRC screening practices
and outcomes; clinics’ quality
improvement and monitoring activities;
E:\FR\FM\03DEN1.SGM
03DEN1
78133
Federal Register / Vol. 85, No. 233 / Thursday, December 3, 2020 / Notices
EBI implementation; additional factors
that affect EBI implementation over
time; and the effect of COVID–19 on
CRCCP implementation at the clinic
level.
The new Quarterly Program Update
survey will collect standardized
awardee-level information on aspects of
program management, including (1)
respondent information, (2) award
spending, (3) staff vacancies, (4)
program successes and challenges, (5)
TA needs, and (6) COVID–19. This
information collection will provide CDC
staff rapid reporting of programmatic
information to inform their efforts to
provide awardees with tailored TA.
Redesigned data elements will enable
CDC to better gauge progress in meeting
CRCCP program goals and monitor
implementation activities, evaluate
outcomes, and identify awardee TA
needs. In addition, data collected will
inform program improvement and help
identify successful activities that need
to be maintained, replicated, or
expanded.
OMB approval is requested for three
years. The number of awardees will
increase from 30 to 35 awardees, and
the number of clinic partners is
expected to increase from 12 to 24 per
awardee. Therefore, the total estimated
annualized burden hours have increased
from 204 to 760 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
CRCCP Awardees ........................
CRCCP Annual Awardee Survey .....................................
CRCCP Clinic-level Data Collection Instrument ..............
CRCCP Quarterly Program Update .................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–26631 Filed 12–2–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1108; Docket No. CDC–2020–
0119]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on the
existing information collection project
titled Paul Coverdell National Acute
Stroke Program (PCNASP) reporting
system, which was established to
improve quality of care for acute stroke
patients from onset of signs and
symptoms through hospital care and
rehabilitation and recovery.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
VerDate Sep<11>2014
19:48 Dec 02, 2020
Jkt 253001
CDC must receive written
comments on or before February 1,
2021.
DATES:
You may submit comments,
identified by Docket No. CDC–2020–
0119 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
ADDRESSES:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
35
35
35
1
24
4
Average
burden per
response
(in hr)
15/60
50/60
22/60
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Paul Coverdell National Acute Stroke
Program (PCNASP) (OMB Control No.
0920–1108, Exp. 09/30/2022)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\03DEN1.SGM
03DEN1
]]>Agencies
[Federal Register Volume 85, Number 233 (Thursday, December 3, 2020)]
[Notices]
[Pages 78132-78133]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1074]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Colorectal Cancer Control (CRCCP) Monitoring
Activities to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on June 5,
2020 to obtain comments from the public and affected agencies. CDC
received two non-substantive public comments and provided responses to
each. This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Colorectal Cancer Control Program (CRCCP) Monitoring Activities
(OMB Control No. 0920-1074, Exp. 7/31/2020)--Reinstatement with
Change--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a Reinstatement with Change to OMB Control No.
0920-1074. CDC proposes use of a modified annual grantee survey
instrument (renamed ``Annual Awardee Survey''), a modified clinic-level
data collection instrument, and a new awardee-level Quarterly Program
Update. The number of respondents will increase from 30 to 35 awardees,
and the total estimated annualized burden will increase.
Colorectal cancer (CRC) is the second leading cause of death from
cancer in the United States among cancers that affect both men and
women. There is substantial evidence that CRC screening reduces the
incidence of and death from the disease. Screening for CRC can detect
disease early, when treatment is more effective, and prevent cancer by
finding and removing precancerous polyps. Of individuals diagnosed with
early stage CRC, more than 90% live five or more years. To reduce CRC
morbidity, mortality, and associated costs, use of CRC screening tests
must be increased among age-eligible adults with the lowest CRC
screening rates.
The purpose of the Colorectal Cancer Control Program (CRCCP) is to
partner with health systems and their individual primary care clinics
to implement evidence-based interventions (EBIs) to increase CRC
screening among defined populations of adults ages 50-75 that have CRC
screening rates lower than the national, regional, or local rate.
In 2020, CDC issued a new funding opportunity, Public Health and
Health System Partnerships to Increase Colorectal Cancer Screening in
Clinical Settings (DP20-2002), a five-year cooperative agreement to
increase CRC screening among defined populations of adults ages 50-75
that have CRC screening rates lower than the national, regional, or
local rate. DP20-2002 funds recipients to partner with health systems
and their primary care clinics to implement multiple EBIs, partner with
organizations to support implementation of EBIs in those clinics, and
collect high-quality clinic-level data when a clinic is recruited to
participate (baseline) and annually thereafter to monitor EBI
implementation and assess screening rate changes. DP20-2002 eliminates
funding to provide direct clinical service delivery. However, DP20-2002
requires recipients to conduct a formal readiness assessment of
potential clinics to implement EBIs, use assessment findings to select
appropriate EBIs for implementation, and provide clinics with limited
financial resources to support follow-up colonoscopies for under- and
uninsured patients after an abnormal CRC screening test.
CDC proposes three information collections--a modified Annual
Awardee Survey, a modified Clinic-Level Data Collection Instrument, and
a new awardee-level Quarterly Program Update--to reflect modified goals
for the new cooperative agreement and a modified monitoring plan.
The Annual Awardee Survey eliminates questions related to clinic
service delivery, which is no longer funded under DP20-2002. In
addition, many program management questions were eliminated and will
now be gathered via the Quarterly Program Update on a quarterly basis
to better inform CDC technical assistance (TA). The survey now includes
five items regarding the effect of COVID-19 on CRCCP implementation at
the grantee level.
The modified clinic-level data collection instrument was
reorganized for increased efficiency and overall data quality
improvement. In addition, wording and responses for many variables and
their response options have undergone minor revisions to better capture
awardees' partnerships with both health systems and clinics, and
appropriate capture of baseline and annual variables. The instrument
gathers information to assess health system and clinic characteristics;
program reach; CRC screening practices and outcomes; clinics' quality
improvement and monitoring activities;
[[Page 78133]]
EBI implementation; additional factors that affect EBI implementation
over time; and the effect of COVID-19 on CRCCP implementation at the
clinic level.
The new Quarterly Program Update survey will collect standardized
awardee-level information on aspects of program management, including
(1) respondent information, (2) award spending, (3) staff vacancies,
(4) program successes and challenges, (5) TA needs, and (6) COVID-19.
This information collection will provide CDC staff rapid reporting of
programmatic information to inform their efforts to provide awardees
with tailored TA.
Redesigned data elements will enable CDC to better gauge progress
in meeting CRCCP program goals and monitor implementation activities,
evaluate outcomes, and identify awardee TA needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded.
OMB approval is requested for three years. The number of awardees
will increase from 30 to 35 awardees, and the number of clinic partners
is expected to increase from 12 to 24 per awardee. Therefore, the total
estimated annualized burden hours have increased from 204 to 760 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Awardees........................ CRCCP Annual Awardee 35 1 15/60
Survey.
CRCCP Clinic-level Data 35 24 50/60
Collection Instrument.
CRCCP Quarterly Program 35 4 22/60
Update.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-26631 Filed 12-2-20; 8:45 am]
BILLING CODE 4163-18-P
